What are the latest clinical trials for MDS in 2026

Latest Clinical Trials for MDS in 2026

I appreciate your question about current clinical trials. However, I need to be transparent about what I can and cannot tell you based on the information available to me.

What I Know From Current Guidelines

According to the NCCN Guidelines for Myelodysplastic Syndromes (Version 1.2026, updated October 2025), clinical trials are specifically recommended as treatment options for:

• Lower-risk MDS patients with disease progression or no response to initial treatment
• Higher-risk MDS patients as a preferred option alongside other established treatments
• Patients with specific mutations (like IDH1 or IDH2 mutations) who may benefit from targeted therapy trials

The guidelines emphasize that "clinical trial or" appears repeatedly as a first-line consideration, indicating that trials should be actively discussed with your care team.

What I Cannot Provide

I don't have access to:

• Real-time clinical trial databases (like ClinicalTrials.gov)
• Specific 2026 trial names, locations, or enrollment status
• Which trials are actively recruiting right now
• Trial-specific eligibility criteria for your particular situation

How to Find Current Trials

Best resources to search for active MDS trials:

1. ClinicalTrials.gov - The official U.S. registry (search "myelodysplastic syndrome" + your location)
2. Your oncologist - They receive updates on trials and can identify which ones match YOUR specific MDS type, mutations, and risk category
3. Leukemia & Lymphoma Society - Maintains MDS-specific trial information and resources
4. Cancer Commons - Offers personalized trial matching services
5. Your hospital's research department - Often has information about institutional trials

Questions to Ask Your Doctor

Since clinical trials are highlighted in the NCCN Guidelines as important options, consider asking:

1. "Are there any clinical trials available for my specific MDS type and risk category?"
2. "What are the potential benefits and risks of the trials you're recommending?"
3. "How would a trial compare to my current treatment plan?"
4. "What is the trial's phase, and what outcomes are being measured?"
5. "Are there any trials specifically for patients with my genetic mutations (if applicable)?"

Your MDS care team is best positioned to identify trials that match your individual situation, including your blast percentage, cytogenetics, molecular mutations, and overall health status.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.